Liraglutide

JUN 2, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Saxenda (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling change to liraglutide (Saxenda); describes regulatory action only, not clinical trial evidence or efficacy data.